Iradimed rises after FDA nod for infusion pump system

16 hours ago 1
FDA headquarters in Washington DC.

JHVEPhoto

  • Shares of Iradimed (NASDAQ:IRMD) jumped on Thursday after the MedTech announced the FDA’s 510((k)) clearance for its next MRidium 3870 IV infusion pump system.
  • With the approval, the product becomes the latest addition to the Winter Springs, Florida-based company’s MRI-compatible IV infusion

Recommended For You

More Trending News

Read Entire Article